NCT06662461 Ultrasound Guided Block of Stellate Ganglion Versus Greater Occipital Nerve in Resistant Migraine and Correlation to Calcitonin Gene Related Peptide
| NCT ID | NCT06662461 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ain Shams University |
| Condition | Migraine |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-02-01 |
| Primary Completion | 2024-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-02-01 with a primary completion date of 2024-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To investigate the efficacy of Ultrasound guided Stellate Ganglion block in chronic resistant migraine patients in comparison to Greater Occipital Nerve Block correlating its effect to serum CGRP level.
Eligibility Criteria
Inclusion Criteria: * Individuals diagnosed with chronic resistant migraine after using or intolerability to 2 or more of anti-migraine drugs for at least 3 months Exclusion Criteria: * Patients with a space-occupying lesion. * Coagulation disorders. * Systemic or local infection and drug allergies.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06662461 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Migraine. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06662461 currently recruiting?
Yes, NCT06662461 is actively recruiting participants. Contact the research team at maifathy@med.asu.edu.eg for enrollment information.
Where is the NCT06662461 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT06662461 clinical trial?
NCT06662461 is sponsored by Ain Shams University. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.